CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
CytoDyn Inc.
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026
- Market cap
- $345.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0168 (−6.30%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Aug 31, 2026
Valuation
- Market cap
- $345.56M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$57.10M
- EPS, diluted
- -$0.04
- Book value per share
- -$0.07
- Diluted shares
- 1.38B
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$40.21M
Net income
-$57.10M
EPS, diluted
-$0.04
Free cash flow
–
Reported periodTrailing twelve months